Literature DB >> 5646434

Radioactive xenon (133Xe) disappearance rates from the synovial cavity of the human knee joint in normal and arthritic subjects.

R A St Onge, W C Dick, G Bell, J A Boyle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5646434      PMCID： PMC1031084          DOI： 10.1136/ard.27.2.163

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  MEASUREMENT OF BLOOD-FLOW THROUGH SKELETAL MUSCLE BY INTRAMUSCULAR INJECTION OF XENON-133.

Authors:  N A LASSEN; J LINDBJERG; O MUNCK
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

2.  The absorption of serum albumin and gamma globulin from the knee joint of man and rabbit.

Authors:  G P RODNAN; M J MACLACHLAN
Journal:  Arthritis Rheum       Date:  1960-04

3.  Clearance of radioactive sodium from the knee joint.

Authors:  R HARRIS; J B MILLARD
Journal:  Clin Sci       Date:  1956-02       Impact factor: 6.124

4.  The clearance of Na24 from the normal and osteo-arthritic knee joint and the response to intra-arterial priscoline.

Authors:  S DAVISON; L H WISHAM
Journal:  J Clin Invest       Date:  1958-03       Impact factor: 14.808

5.  Radiosodium clearance from the knee joint in rheumatoid arthritis.

Authors:  R HARRIS; J B MILLARD; S K BANERJEE
Journal:  Ann Rheum Dis       Date:  1958-06       Impact factor: 19.103

6.  Proposed diagnostic criteria for rheumatoid arthritis.

Authors:  G A BENNETT; S COBB; R JACOX; R A JESSAR; M W ROPES
Journal:  Bull Rheum Dis       Date:  1956-12

7.  Disappearance of radioactive serum albumin from joints in rheumatoid arthritis.

Authors:  S AHLSTROM; P O GEDDA; H HEDBERG
Journal:  Acta Rheumatol Scand       Date:  1956

8.  Transport of radioactive sodium across the synovial membrane of normal human subjects.

Authors:  R F JACOX; M K JOHNSON; R KOONTZ
Journal:  Proc Soc Exp Biol Med       Date:  1952 Aug-Sep
  8 in total
  7 in total

1.  Biomimetic molecules lower catabolic expression and prevent chondroitin sulfate degradation in an osteoarthritic ex vivo model.

Authors:  Shaili Sharma; Nelda Vazquez-Portalatin; Sarah Calve; Alyssa Panitch
Journal:  ACS Biomater Sci Eng       Date:  2015-12-23

2.  Inorganic pyrophosphate pool size and turnover rate in arthritic joints.

Authors:  M Camerlain; D J McCarty; D C Silcox; A Jung
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  Effect of anti-inflammatory drug therapy on clearance of 133-Xe from knee joints of patients with rheumatoid arthritis.

Authors:  C Dick; P H Dick; G Nuki; K Whaley; J A Boyle; A Shenkin; W W Downie; W W Buchanan
Journal:  Br Med J       Date:  1969-08-02

4.  Clearnace of Fe59-labelled erythrocytes from normal and inflamed rabbit knee joints. I. Relationship to the anaemia of rheumatoid arthritis.

Authors:  K D Muirden
Journal:  Ann Rheum Dis       Date:  1969-09       Impact factor: 19.103

5.  Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging.

Authors:  K Gaffney; J Cookson; S Blades; A Coumbe; D Blake
Journal:  Ann Rheum Dis       Date:  1998-03       Impact factor: 19.103

6.  A physiological approach to the assessment of disease activity in rheumatoid arthritis.

Authors:  E J Goetzl; K H Falchuk; L S Zeiger; A L Sullivan; C L Hebert; J P Adams; J L Decker
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

7.  Disappearance kinetics of solutes from synovial fluid after intra-articular injection.

Authors:  S G Owen; H W Francis; M S Roberts
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.